{"disease":{"id":"oocyte-donation","name":"oocyte donation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04731012","title":"Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT07263490","title":"PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)","phase":"","overall_status":"RECRUITING","enrollment_count":462,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT03668184","title":"What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT03088735","title":"Transfer Strategy in an Oocyte Donation Programme","phase":"NA","overall_status":"TERMINATED","enrollment_count":134,"lead_sponsor_name":"Fundacion Dexeus","has_results":false},{"nct_id":"NCT05521828","title":"Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"CRG UZ Brussel","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}